Net gamma exposure for Pacific Biosciences of California Inc (PACB) options was positive at the Nov 4, 2026 close, about $386.93K per 1% move in the stock. It has been positive on 20 of the last 20 trading days. With positive gamma, dealer hedging tends to lean against price moves, which can dampen swings.
Upgrade to unlock Gamma Flip, Gamma Profile, Call Wall, Put Wall, and multiple expiration dates.
Gamma Exposure by Strike
Showing results for PACB, 2026-11-20(m), calls & puts
Gamma Exposure Stats
Showing results for PACB, 2026-11-20(m), calls & puts
Net Gamma Exposure by Expiration
Showing results for PACB, 2026-11-20(m), calls & puts. View all expiries
| Expiration | Net GEX | Call GEX | Put GEX | Call Wall | Put Wall | Gamma Flip |
|---|
PACB Gamma Exposure FAQ
What is gamma exposure (GEX)?
Gamma exposure estimates how much stock option dealers must buy or sell to stay hedged for each 1% move in the underlying.
Is PACB gamma exposure positive or negative?
Pacific Biosciences of California net gamma exposure was positive on Nov 4, 2026, at $386.93K. It has been positive on 20 of the last 20 trading days.
How has PACB gamma exposure changed recently?
Pacific Biosciences of California net gamma exposure went from $298.56K on Oct 7, 2026 to $386.93K on Nov 4, 2026. See the PACB gamma exposure history for a longer view.
What is Pacific Biosciences of California Inc?
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems.